Market Overview:
The global enteric disease testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of enteric diseases, rising awareness about diagnostic tests, and technological advancements in the field of diagnostics. The global enteric disease testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into C. difficile, campylobacteriosis, cholera, E. coli infections (including UTIs), H. pylori infection,, salmonellosis,, shigellosis,. On the basis of application,.the market is segmented into hospitals,, research centers,, and clinics.On the basis of region,.the global enteric disease testing market is divided into North America., Latin America., Europe., Asia Pacific., and Middle East & Africa. Some key players operating in this space are Abbott Laboratories (US), bioMérieux SA (France), Danaher Corporation (US), F Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG(Germany)and Thermo Fisher Scientific Inc.(US).
Product Definition:
Enteric Disease Testing is the process of detecting and identifying viruses, bacteria, or parasites that can cause intestinal infections. The importance of Enteric Disease Testing is to help identify and treat the infections as quickly as possible to prevent further illness.
C. difficile:
C. difficile is a gram-positive bacteria that normally lives in the gut and intestine. However, when C. difficile grows out of control, it can cause severe diarrhea (enteric disease) which has been referred to as CDI or C Difficulties or Clostridium difficile infection. The incidence rate of this infection is approximately 30 cases per 100,000 population annually with a mortality rate of about 0.3%.
Campylobacteriosis:
Campylobacteriosis is a bacterial infection of the small intestine. The disease is commonly found in animals and can also infect humans, although rare cases have been reported. It generally affects poultry but can also affect cattle and other herbivores. The bacteria are found in soil, water, plants or crops where there has been contact with infected animal dung or waste products from infected birds or animals (such as cats).
Application Insights:
The market is segmented based on the application as hospitals, research centers, and clinics. Hospitals were estimated to be the largest application segment in 2017 owing to rising prevalence of hospital-acquired infections and increasing number of deaths due to food poisoning. The growth in hospital-acquired infections is primarily attributed to growing number of patients that are admitted by hospitals every year which has resulted in increased demand for enteric disease testing at this end point.
Research centers accounted for a significant share owing to rise in funding initiatives such as NCBI¢â‚¬â„¢s Research Support grant program which funds research studies on various aspects concerning enteric diseases along with other digestive disorders that affect humans. Rise in funding has led researchers at different institutions worldwide who are working towards development of effective diagnostics tools against these diseases thereby contributing towards growth of this segment over the forecast period.
Regional Analysis:
North America dominated the global enteric disease testing market in 2017. The presence of sophisticated healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending and better reimbursement scenario are some of the key factors responsible for its large share. Moreover, increasing incidence rates of these diseases have been reported from this region which has further propelled market growth. For instance, according to CDC estimates around 1 in 2 people will get infected with campylobacter during their lifetime and about 93,000 cases were reported in U.S., alone during 2015-2016 period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising disposable income leading to an increase in demand for various advanced medical products & services along with growing penetration of generic drugs due to patent expirations or regulatory changes by governments across various countries such as India & China.
Growth Factors:
- Increasing incidence of enteric diseases: The global incidence of enteric diseases is increasing due to the changing lifestyle and dietary habits, growing population, and environmental changes. This is driving the demand for Enteric Disease Testing market.
- Growing awareness about Enteric Diseases: There is a growing awareness among people about the symptoms and treatment of various types of enteric diseases. This is propelling the demand for Enteric Disease Testing market products and services worldwide.
- Technological advancements in diagnostics: The technological advancements in diagnostics are helping to improve the accuracy and speed of diagnosis of various types of enteric diseases. This is fueling the growth prospects for Enteric Disease Testing market globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Enteric Disease Testing Market Research Report
By Type
C. difficile, Campylobacteriosis, Cholera, E.Coli, H.Pylori, Salmonellosis, Shigellosis
By Application
Hospitals, Research Centers, Clinics
By Companies
Abbott, Becton, Dickinson, Bio Rad Laboratories, Biomerica, Cepheid, Coris BioConcept, DiaSorin, Meridian BioSceinces, Quest Diagnostics, bioMerieux
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
129
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Enteric Disease Testing Market Report Segments:
The global Enteric Disease Testing market is segmented on the basis of:
Types
C. difficile, Campylobacteriosis, Cholera, E.Coli, H.Pylori, Salmonellosis, Shigellosis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research Centers, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Becton, Dickinson
- Bio Rad Laboratories
- Biomerica
- Cepheid
- Coris BioConcept
- DiaSorin
- Meridian BioSceinces
- Quest Diagnostics
- bioMerieux
Highlights of The Enteric Disease Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- C. difficile
- Campylobacteriosis
- Cholera
- E.Coli
- H.Pylori
- Salmonellosis
- Shigellosis
- By Application:
- Hospitals
- Research Centers
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Enteric Disease Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Enteric disease testing is a procedure that is used to determine the presence of enteric bacteria in the digestive system. This test can be used to screen for conditions such as diarrhea, gastritis, and food poisoning.
Some of the key players operating in the enteric disease testing market are Abbott, Becton, Dickinson, Bio Rad Laboratories, Biomerica, Cepheid, Coris BioConcept, DiaSorin, Meridian BioSceinces, Quest Diagnostics, bioMerieux.
The enteric disease testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Enteric Disease Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Enteric Disease Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Enteric Disease Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Enteric Disease Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Enteric Disease Testing Market Size & Forecast, 2018-2028
4.5.1 Enteric Disease Testing Market Size and Y-o-Y Growth
4.5.2 Enteric Disease Testing Market Absolute $ Opportunity
Chapter 5 Global Enteric Disease Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Enteric Disease Testing Market Size Forecast by Type
5.2.1 C. difficile
5.2.2 Campylobacteriosis
5.2.3 Cholera
5.2.4 E.Coli
5.2.5 H.Pylori
5.2.6 Salmonellosis
5.2.7 Shigellosis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Enteric Disease Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Enteric Disease Testing Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Research Centers
6.2.3 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Enteric Disease Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Enteric Disease Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Enteric Disease Testing Analysis and Forecast
9.1 Introduction
9.2 North America Enteric Disease Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Enteric Disease Testing Market Size Forecast by Type
9.6.1 C. difficile
9.6.2 Campylobacteriosis
9.6.3 Cholera
9.6.4 E.Coli
9.6.5 H.Pylori
9.6.6 Salmonellosis
9.6.7 Shigellosis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Enteric Disease Testing Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Research Centers
9.10.3 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Enteric Disease Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Enteric Disease Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Enteric Disease Testing Market Size Forecast by Type
10.6.1 C. difficile
10.6.2 Campylobacteriosis
10.6.3 Cholera
10.6.4 E.Coli
10.6.5 H.Pylori
10.6.6 Salmonellosis
10.6.7 Shigellosis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Enteric Disease Testing Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Research Centers
10.10.3 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Enteric Disease Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Enteric Disease Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Enteric Disease Testing Market Size Forecast by Type
11.6.1 C. difficile
11.6.2 Campylobacteriosis
11.6.3 Cholera
11.6.4 E.Coli
11.6.5 H.Pylori
11.6.6 Salmonellosis
11.6.7 Shigellosis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Enteric Disease Testing Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Research Centers
11.10.3 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Enteric Disease Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Enteric Disease Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Enteric Disease Testing Market Size Forecast by Type
12.6.1 C. difficile
12.6.2 Campylobacteriosis
12.6.3 Cholera
12.6.4 E.Coli
12.6.5 H.Pylori
12.6.6 Salmonellosis
12.6.7 Shigellosis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Enteric Disease Testing Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Research Centers
12.10.3 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Enteric Disease Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Enteric Disease Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Enteric Disease Testing Market Size Forecast by Type
13.6.1 C. difficile
13.6.2 Campylobacteriosis
13.6.3 Cholera
13.6.4 E.Coli
13.6.5 H.Pylori
13.6.6 Salmonellosis
13.6.7 Shigellosis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Enteric Disease Testing Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Research Centers
13.10.3 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Enteric Disease Testing Market: Competitive Dashboard
14.2 Global Enteric Disease Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Becton, Dickinson
14.3.3 Bio Rad Laboratories
14.3.4 Biomerica
14.3.5 Cepheid
14.3.6 Coris BioConcept
14.3.7 DiaSorin
14.3.8 Meridian BioSceinces
14.3.9 Quest Diagnostics
14.3.10 bioMerieux
